Cas:163271-06-5 1-Benzyl-4-methyl-4-piperidinamine manufacturer & supplier

Chemical Name:1-Benzyl-4-methyl-4-piperidinamine

CAS.NO:163271-06-5

Synonyms:1-benzyl-4-methyl-4-piperidineamine;4-Amino-1-benzyl-4-methylpiperidine;4-amino-l-benzyl-4-methylpiperidine;1-Benzyl-4-methyl-4-piperidinamine;1-benzyl-4-methyl-piperidin-4-amine;4-methyl-1-(phenylmethyl)-4-piperidinamine;4-methyl-1-(phenylmethyl)piperidin-4-amine;4-Piperidinamine, 4-methyl-1-(phenylmethyl)-;1-benzyl-4-methyl-piperidin-4-ylamine

Molecular Formula:C₁₃H₂₀N₂

Molecular Weight:204.311

HS Code:2933399090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:286.3±33.0 °C at 760 mmHg

Density:1.0±0.1 g/cm3

Index of Refraction:1.547

PSA:29.26000

Exact Mass:204.162643

LogP:1.90

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-benzyl-4-methyl-4-piperidineamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-benzyl-4-methyl-piperidin-4-ylamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-amino-l-benzyl-4-methylpiperidine Use and application,1-Benzyl-4-methyl-4-piperidinamine technical grade,usp/ep/jp grade.

Related News: Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs. 1-Benzyl-4-methyl-4-piperidinamine manufacturer Separately, Europe’s drug regulator said on Friday that batches of J&J COVID-19 vaccine made for the region around the time the contamination issues were revealed at the Baltimore plant would, as a precaution, not be used. 1-Benzyl-4-methyl-4-piperidinamine supplier Fate Therapeutics has exclusively licensed from MSK foundational intellectual property covering the production and composition of iPSC-derived T cells. 1-Benzyl-4-methyl-4-piperidinamine vendor Adding Darzalex to Bristol Myers Squibb’s Revlimid and steroid dexamethasone (Rd) could slash the risk of death by 32% in newly diagnosed multiple myeloma patients ineligible to receive stem cell transplants, J&J reported at the European Hematology Association’s virtual congress. 1-Benzyl-4-methyl-4-piperidinamine factory Adding Darzalex to Bristol Myers Squibb’s Revlimid and steroid dexamethasone (Rd) could slash the risk of death by 32% in newly diagnosed multiple myeloma patients ineligible to receive stem cell transplants, J&J reported at the European Hematology Association’s virtual congress.